These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9883371)

  • 21. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
    Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fischer GF; Faé I; Kalhs P; Pohlreich D; Kouba M; Dobrovolna M; Greinix HT
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1400-6. PubMed ID: 19822299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential recognition of a BCR/ABL peptide by lymphocytes from normal donors and chronic myeloid leukemia patients.
    Bertazzoli C; Marchesi E; Passoni L; Barni R; Ravagnani F; Lombardo C; Corneo GM; Pioltelli P; Pogliani E; Gambacorti-Passerini C
    Clin Cancer Res; 2000 May; 6(5):1931-5. PubMed ID: 10815918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
    Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of allogeneic bone marrow transplantation in patients with acute leukemia in complete remission and in patients with chronic myeloid leukemia during the chronic phase].
    Liubimova LS; Savchenko VG; Mendeleeva LP; Kliasova GA; Gribanova EO; Demidova IA; Gal'tseva IV; Kuz'mina LA; Momotiuk KS; Kuliev RG
    Ter Arkh; 1999; 71(7):27-32. PubMed ID: 10481864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunological and hematological reconstruction of recipients in bone marrow transplantation from closely related donors].
    Zotikov EA; Poreshina LP; Kut'ina RM; Vasil'eva MN; Liubimova LS; Mendeleeva LP; Savchenko VG
    Klin Lab Diagn; 1997 Jan; (1):10-3. PubMed ID: 9091124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
    Martinelli G; Montefusco V; Testoni N; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazi F; Rosti G; Bandini G; Tura S
    Haematologica; 2000 Jun; 85(6):653-8. PubMed ID: 10870124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.
    van der Meer A; Schaap NP; Schattenberg AV; van Cranenbroek B; Tijssen HJ; Joosten I
    Mol Immunol; 2008 Aug; 45(13):3631-8. PubMed ID: 18555529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic bone marrow transplantation of chronic myeloid leukemia from an HLA-matched unrelated donor with the beta-thalassemic trait.
    Sue YC; Liu TC; Chang CS; Huang SM; Chen TP; Lin SF
    Int J Hematol; 1999 Apr; 69(3):200-2. PubMed ID: 10222660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary study of HLA-ABCDR antigens in CML, ANLL, thalassemia and severe aplastic anemia in Thais.
    Chiewsilp P; Sujirachato K; Mongkolsuk T; Junpong S; Jootar S; Hathirat P
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S130-6. PubMed ID: 10865419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cord blood transplantation for adult patients with hematological malignancies.
    Yamane T; Nakamae H; Hasegawa T; Terada Y; Hagihara K; Ohta K; Hino M
    Osaka City Med J; 2005 Dec; 51(2):83-8. PubMed ID: 16617685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transplant induction of donor-type anti-RhD antibodies production shortly followed by complete hemolysis of recipient-type erythrocytes in RhD-mismatched allogeneic bone marrow recipient.
    Markiewicz M; Wojnar J; Giebel S; Wieczorkiewicz A; Wylezoł I; Hołowiecki J
    Bone Marrow Transplant; 2006 Feb; 37(4):433-4. PubMed ID: 16400335
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparable outcomes of HLA-matched unrelated and HLA-identical sibling donor bone marrow transplantation for childhood acute myeloid leukemia in first remission.
    Lee DH; Kwon YJ; Lim J; Kim Y; Han K; Chung NG; Jeong DC; Cho B; Kim HK
    Pediatr Transplant; 2009 Mar; 13(2):210-6. PubMed ID: 18627512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases].
    He Y; Feng SZ; Wang M; Wei JL; Qin TJ; Zhou Z; Zhai WJ; Qiu LG; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of interferon-alpha on the prognosis of bone marrow transplantation in chronic myeloid leukemia].
    Xu L; Guo N; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):589-91. PubMed ID: 11855148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.
    Benjamin RJ; Connors JM; McGurk S; Churchill WH; Antin JH
    Biol Blood Marrow Transplant; 1998; 4(3):151-6. PubMed ID: 9923413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.